Product Information
FT PAIN RELIEF 200 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0322 per EA under NDC 70677124401. Its NADAC has been published 108 times since Jul 10, 2024.
FDA first approved this application on Mar 28, 2011.
The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677124401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA079129FDA Approved
3/28/2011
On Market Since
2/2/2024
Pharmacological Classes
Price Statistics
The NADAC for FT PAIN RELIEF 200 MG TABLET has been published 108 times since Jul 10, 2024, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0322 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0313 (May 21, 2025) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0337 |
| Average price | $0.0340 |
| Largest weekly change | +7.7% (Sep 18, 2024) |
| Weeks tracked | 108 |
| Tracking since | Jul 10, 2024 |
1W
N/A
1M
N/A
3M
+0.6%
6M
-1.8%
1Y
-11.5%
3Y
N/A
5Y
N/A
All
-5.4%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT PAIN RELIEF 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FT PAIN RELIEF 200 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.0322 per EA (NDC 70677124401), effective Jul 29, 2026.
How has the price of FT PAIN RELIEF 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for FT PAIN RELIEF 200 MG TABLET has declined 5.4%. It has been tracked across 108 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for FT PAIN RELIEF 200 MG TABLET?
Since Jul 10, 2024, the NADAC for FT PAIN RELIEF 200 MG TABLET has ranged from a low of $0.0313 (May 21, 2025) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0337 per EA.
Are there cheaper alternatives to FT PAIN RELIEF 200 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 16% below FT PAIN RELIEF 200 MG TABLET.
Who manufactures FT PAIN RELIEF 200 MG TABLET?
FT PAIN RELIEF 200 MG TABLET (NDC 70677124401) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.